Ausiello Dennis A — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Ausiello Dennis A has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $13.73M.

Profile

Ausiello Dennis A

Dennis A. Ausiello is a corporate director known for his involvement with several biotechnology companies, including Rani Therapeutics Holdings, Alnylam Pharmaceuticals, and Seres Therapeutics. He has held various roles in the pharmaceutical industry, contributing to advancements in RNA interference therapeutics.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-22ALNYALNYLAM PHARMACEUTICALS, INC.A — Grant or award671$0.00
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale641$442.66$284K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale1.2K$441.88$532K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale1.2K$440.54$545K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale5.3K$439.27$2.33M
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale2.1K$438.34$914K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale1.9K$437.56$841K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale5.4K$436.00$2.34M
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale7.7K$435.40$3.34M
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale2.1K$434.50$912K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale1.9K$432.94$839K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.S — Open-market sale2.0K$430.81$855K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.M — Option exercise3.5K$189.87$656K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.M — Option exercise4.0K$171.95$693K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.M — Option exercise5.2K$151.22$791K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.M — Option exercise4.6K$148.77$682K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.M — Option exercise5.2K$128.31$661K
2025-08-14ALNYALNYLAM PHARMACEUTICALS, INC.M — Option exercise9.0K$72.01$648K
2025-05-08ALNYALNYLAM PHARMACEUTICALS, INC.A — Grant or award775$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Ausiello Dennis A?

Dennis A. Ausiello is a corporate director known for his involvement with several biotechnology companies, including Rani Therapeutics Holdings, Alnylam Pharmaceuticals, and Seres Therapeutics. He has held various roles in the pharmaceutical industry, contributing to advancements in RNA interference therapeutics.…

How many SEC Form 4 filings has Ausiello Dennis A submitted recently?

4 primary Form 4 filings in the last 90 days, covering 3 companies.

Has Ausiello Dennis A been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 11 open-market sales ($13.73M) across all tracked filings.

Where can I see all of Ausiello Dennis A's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Ausiello Dennis A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.